The Newly Discovered Ring Structure of RAD52 Protein May Lead to New Treatments for BRCA-Deficient Cancers
The RAD52 protein is a coveted drug target for precision oncology because while it is largely dispensable in healthy human cells, the protein is essential for survival of cancer cells that are deficient in DNA repair function, such as those with defective BRCA1 or BRCA2 genes
Read More